Scar and skin texture improvement with Morpheus8 RF microneedling at Berkshire Aesthetics

Morpheus8 RF Microneedling in Maidenhead

Morpheus8 combines microneedling with radiofrequency energy to stimulate collagen and elastin remodelling in deeper skin layers. At Berkshire Aesthetics in Maidenhead, suitability is assessed during a doctor-led consultation and treatment is tailored to your skin, concerns and goals.

Book Consultation
Book a Consultation

Clinically reviewed by

Dr Selena LangdonMedical Director, MBBS

GMC 6159259

Last reviewed:

Information is general and not a substitute for a medical consultation. Suitability is confirmed during assessment.

Why we start with a consultation

Every treatment begins with a medical assessment. We need to understand your medical history, current health, skin condition and concerns before prescribing any procedure. This protects your safety and ensures the treatment is clinically appropriate for you.

During your consultation, Dr Langdon will explain what the treatment can realistically achieve, any risks specific to you, and whether an alternative might be more appropriate.

All bookings are subject to our Booking Conditions.

Doctor-led approach

Clinical overview

Morpheus8 is a fractional radiofrequency microneedling device that delivers controlled thermal energy into the deeper layers of the skin via an array of coated microneedles. This combination of mechanical microneedling and radiofrequency heating is intended to stimulate the body's natural wound-healing response, encouraging collagen and elastin remodelling over time. Unlike traditional microneedling, Morpheus8 penetrates to a greater depth and delivers energy in a fractional pattern, treating targeted zones while leaving surrounding tissue intact. This allows treatment of skin laxity, texture irregularities, enlarged pores and acne scarring on the face, neck, jawline and body areas. The device is suitable for all skin tones, as the fractional RF energy is delivered below the skin surface. Results develop progressively over 3–6 months as collagen remodelling takes place. Most patients require a course of 2–3 sessions spaced 4–6 weeks apart, though this is individualised during consultation. Morpheus8 is not a substitute for surgical lifting where significant laxity is present.

Key Benefits

  • Targets skin laxity by stimulating collagen and elastin remodelling
  • Improves skin texture, tone and pore size
  • Can reduce the appearance of fine lines, wrinkles and acne scarring
  • Suitable for face, neck, jawline and body areas
  • Suitable for all skin tones (Fitzpatrick I–VI)
  • Non-surgical alternative to more invasive tightening procedures

Suitable For

  • Those with mild to moderate skin laxity seeking non-surgical tightening
  • Patients wanting improvement in skin texture, tone or pore size
  • Those with acne scarring or post-inflammatory textural irregularities
  • Adults seeking gradual, progressive improvement rather than immediate dramatic change
  • People with all skin tones (the fractional RF approach reduces pigmentation risk compared to some laser treatments)

Not Suitable For

  • Those with active skin infections or severe inflammatory skin conditions in the treatment area
  • Patients with pacemakers, implanted defibrillators or other active electrical implants
  • Those with certain autoimmune conditions that may impair healing (assessed individually)
  • Pregnant or breastfeeding women
  • Patients who have recently completed chemotherapy or radiotherapy (timing discussed at consultation)

Final suitability is confirmed during a medical consultation and assessment.

When we don't recommend it

  • If significant skin laxity requires surgical intervention — Morpheus8 is not a substitute for a facelift and we will be honest about what non-surgical treatments can achieve.
  • If you have active skin infection, severe eczema, psoriasis or other inflammatory skin disease in the treatment area — we will delay until the skin is settled.
  • If you have an active electrical implant (pacemaker, defibrillator) — radiofrequency energy is contraindicated in this setting.
  • If expectations are for immediate, dramatic results — Morpheus8 produces gradual improvement over months and multiple sessions are typically needed.
  • If recent chemotherapy, radiotherapy or immunosuppressive treatment may impair healing — timing is discussed on an individual basis.

What Happens During Treatment

  1. 1Clinical consultation and skin assessment, including medical history, skin type and your goals
  2. 2Discussion of expected outcomes, limitations, risks and alternatives (including when we may recommend a different approach)
  3. 3Treatment planning and consent, with aftercare guidance tailored to your skin and lifestyle
  4. 4Cleansing and application of topical anaesthetic (numbing cream) prior to treatment
  5. 5Morpheus8 treatment delivered to the agreed areas (typically 30–60 minutes)
  6. 6Post-treatment soothing and clear instructions on what is normal, and when to contact us

Downtime & Aftercare

  • Redness and swelling are expected for 2–5 days
  • Mild pinpoint bleeding or crusting may occur immediately after treatment
  • Avoid makeup for 24–48 hours
  • Avoid direct sun exposure and use SPF 30+ for at least 2 weeks
  • Avoid strenuous exercise, saunas and swimming for 48–72 hours
  • If you notice unexpected or worsening symptoms, contact the clinic for advice

Results Timeline

  • Days 1–5: redness, swelling and mild sensitivity are normal as the skin heals
  • Weeks 2–4: initial improvements in skin texture and tone may become noticeable
  • Months 1–3: progressive collagen remodelling continues
  • Months 3–6: optimal results typically develop as collagen and elastin maturation completes

How Long Results May Last

  • Results develop over 3–6 months and can last 12 months or longer depending on individual factors
  • Skin quality, age, lifestyle and sun exposure influence how long improvements are maintained
  • Maintenance sessions may be discussed at review to sustain results

Individual results vary. View our results and photography standards

Risks & Side Effects

Common, Usually Temporary

  • Redness and swelling (expected, usually settles within 2–5 days)
  • Mild pinpoint bleeding or crusting immediately after treatment
  • Temporary skin sensitivity or tightness
  • Minor bruising (varies by individual)

Rare but Serious

  • Post-inflammatory hyperpigmentation (more common in darker skin tones if aftercare is not followed)
  • Scarring (rare, usually associated with incorrect settings or aftercare non-compliance)
  • Infection (rare)
  • Prolonged or worsening swelling, pain or skin changes requiring clinical review

When to Contact Us Urgently

  • Increasing pain, swelling, heat or spreading redness after the initial healing period
  • Signs of infection such as pus, increasing tenderness, fever or feeling unwell
  • Unexpected skin colour changes (darkening or blanching) in the treated area
  • Any symptom that concerns you or worsens rather than improves

Frequently Asked Questions

Results develop over 3–6 months as collagen remodels and can be long-lasting. How long improvements are maintained depends on individual factors including skin quality, age, lifestyle and sun exposure. Maintenance sessions may be discussed at review.
Expect redness and swelling for 2–5 days. Mild pinpoint bleeding or crusting can occur immediately after treatment. Most patients return to normal activities within a few days. Sun protection is important for at least 2 weeks.
Morpheus8 is not suitable for those with active skin infections, severe inflammatory skin conditions, pacemakers or active electrical implants, certain autoimmune disorders, or during pregnancy and breastfeeding. Suitability is confirmed during consultation.
Yes. Morpheus8 can be part of a broader treatment plan that may include skin-quality treatments, chemical peels or other rejuvenation procedures. Timing and sequencing are discussed during consultation to ensure safety and effectiveness.
All Morpheus8 treatments are performed by trained clinicians under medical oversight. Settings are tailored to your skin type and treatment area. We follow manufacturer protocols, provide written aftercare, and offer review appointments to monitor healing and outcomes.
Most patients benefit from 2–3 sessions spaced 4–6 weeks apart. The number of sessions is individualised during consultation based on your skin, concerns and goals.
Yes. Because the radiofrequency energy is delivered beneath the skin surface in a fractional pattern, Morpheus8 is generally suitable for all skin tones (Fitzpatrick I–VI). Aftercare, particularly sun protection, is important to minimise pigmentation risk.
We provide transparent pricing at your consultation, tailored to your treatment plan. Cost depends on the areas treated and number of sessions recommended by your doctor.
Topical numbing cream is applied before treatment to maximise comfort. Most patients describe a warm prickling sensation. Your clinician adjusts settings to your tolerance throughout.
Your first visit is a doctor-led consultation. We assess your skin, discuss your goals, explain what Morpheus8 can realistically achieve, review risks and agree a tailored treatment plan.
Most patients take 2–3 days off for visible redness and swelling to settle. You can work from home the next day if comfortable. Makeup should be avoided for 24–48 hours post-treatment.

Quick Facts

Treatment Time

30–60 minutes per session

Downtime

2–5 days redness and swelling

Results Visible

Progressive over 3–6 months

Sessions

Typically 2–3 sessions, 4–6 weeks apart (individualised)

Guide Price

From £350 – £1,380

Per session; varies by area

Final price confirmed at consultation

Delivered by

Dr Selena Langdon — Medical Director

MBBS, Injectable Trainer, JCCP Ambassador

Why Berkshire Aesthetics

  • Doctor-led clinic — all treatments clinically overseen by Dr Selena Langdon (MBBS)
  • CQC registered — view our registration
  • Consultation-first approach — we assess suitability before recommending treatment
  • Clear complaints process — we take patient feedback seriously

This content is for informational purposes only and does not constitute medical advice. Individual suitability for any treatment is assessed during a consultation. Always seek the guidance of a qualified medical professional with any questions regarding a medical condition or treatment.

Clinical governance

Page last reviewed: 2026-02-09

Reviewed by Dr Selena Langdon, Medical Director (GMC 6159259) — Last reviewed: 2026-02-09

Doctor-Led
CQC Registered
Award-Recognised
Est. 2016

Further Reading & Clinical References

The following external resources provide independent clinical and regulatory information.

Ready to Start Your Journey?

Book a consultation with our expert team today.